Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In the SURMOUNT 1 trial, participants lost an average of 20.9% of their body weight over 72 weeks , demonstrating promising results that can inspire hope and confidence in your weight-loss journey
NPJ Aging 9 , 7 (2023)
Innovent's IBI-3012 ADC program opens a modality nobody else is positioned for
Lau DCW et al
In a dedicated MASLD substudy involving people with obesity and significant liver fat, retatrutide produced effects that many hepatologists considered unprecedented for a drug still in phase 2
US$ 24.81
US$ 26.65
US$ 29.87
US$ 20.65
